This review highlights engineered macrophages’ potential to reshape the tumor microenvironment in cancer immunotherapy, suggesting new therapeutic strategies.
Macrophages strongly influence cancer progression through their adaptable phenotypes and responses to mechanical and biochemical cues. Their abundance across tumors and links to poor outcomes drive interest in macrophage-targeted therapies. This review highlights macrophage mechanobiology, key behaviors, and the potential of engineered macrophages, using genetic (CAR) or non-genetic “Trojan horse” and “backpacking” strategies, to deliver therapies and reshape the immunosuppressive tumor microenvironment.
No takes yet. Share an insight, caveat, or question.
Block et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: